Blackstone Life Sciences VI - BL L.P. — Form D

Blackstone Life Sciences VI - BL L.P. of NEW YORK, NY, a pooled investment fund, filed a Form D exempt-offering notice with the SEC on 2025-11-20. $3.6B was reported sold. Industry: Pooled Investment Fund.

Offering

Issuer

Officers, directors & promoters (32)

Showing 25 of 32 people.

NameRoleLocation
Joseph BarattaExecutive OfficerNew York, NY
Mathias G FavettoExecutive OfficerNew York, NY
John G FinleyExecutive OfficerNew York, NY
Nicholas G GalakatosExecutive OfficerNew York, NY
Elsa G GelinExecutive OfficerNew York, NY
Ilan G HalalExecutive OfficerNew York, NY
Eric G LiawExecutive OfficerNew York, NY
Robert G LiptakExecutive OfficerNew York, NY
Nentcho G NentchevExecutive OfficerNew York, NY
Alicia NovakExecutive OfficerNew York, NY
Chris G PlaccaExecutive OfficerNew York, NY
Victoria G PortnoyExecutive OfficerNew York, NY
Omar G RehmanExecutive OfficerNew York, NY
Christopher G StrianoExecutive OfficerNew York, NY
n/a Blackstone Life Sciences Associates VI L.P.PromoterNew York, NY
n/a BXLS VI L.L.C.PromoterNew York, NY
Eric LiawRelated PersonNew York, NY
Christopher StrianoRelated PersonNew York, NY
Joseph BarattaRelated PersonNew York, NY
Alicia NovakRelated PersonNew York, NY
n/a BXLS VI L.L.C.Related PersonNew York, NY
n/a Blackstone Life Sciences Associates VI L.P.Related PersonNew York, NY
Nentcho NentchevRelated PersonNew York, NY
Omar RehmanRelated PersonNew York, NY
Robert LiptakRelated PersonNew York, NY

Other filings by this issuer (1)

FiledFormOfferingSold
2026-04-02D/A$6.3B$6.3B

More